
Benzinga Pro data, Armata Pharmaceuticals (AMEX:ARMP) reported Q4 sales of $989.00 thousand. Earnings fell to a loss of $6.05 million, resulting in a 11.59% decrease from last quarter. Armata Pharmaceuticals collected $1.25 million in revenue during Q3, but reported earnings showed a $5.42 million loss.